Background: Patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE) experience significant psychological distress, impacting outcomes. While mindfulness-based interventions (MBIs) are beneficial, access is limited. Internet-delivered MBIs (iMBIs) offer an accessible alternative; yet, qualitative understanding of patient experiences with tailored iMBIs for this specific population is lacking.
Objective: This study aimed to explore the facilitators and barriers of patients with HCC post TACE and participated in tailored iMBIs.
Methods: From November 2020 to December 2022, 11 patients with HCC post TACE who had taken part in tailored iMBIs were purposively recruited from a tertiary hospital in Jilin Province. Data were collected through semistructured interviews lasting 30-60 minutes. The interviews were analyzed using conventional content analysis.
Results: Five main categories emerged from the analysis: (1) mindfulness mindset, including acceptance, calmness, and mood improvement; (2) improvement of physical discomfort, such as better sleep, pain relief, reduced gastrointestinal symptoms, and increased activity levels; (3) resistance to mindfulness practice, including perceived lack of effectiveness, unsuitable conditions, equipment limitations, and difficulty concentrating; (4) support and encouragement, involving social support, supervision, and professional guidance; and (5) accessibility and convenience characterized by restoration of life balance and user-friendly features of the practice. Each category encompassed several subcategories reflecting the diverse experiences of participants.
Conclusions: While iMBIs were generally perceived as convenient and accessible, challenges such as equipment limitations were noted. Future implementation should focus on enhancing supportive factors to improve adherence, minimizing barriers, and refining the design and delivery of iMBI programs.
Trial registration: Chinese Clinical Trial Registry ChiCTR1900027976; https://www.chictr.org.cn/showproj.html?proj=46657.
{"title":"Tailored Internet-Delivered Mindfulness-Based Interventions for Patients With Hepatocellular Carcinoma After Transarterial Chemoembolization: Qualitative Study.","authors":"Zengxia Liu, Min Li, Yong Jia, Li Chen","doi":"10.2196/78337","DOIUrl":"10.2196/78337","url":null,"abstract":"<p><strong>Background: </strong>Patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE) experience significant psychological distress, impacting outcomes. While mindfulness-based interventions (MBIs) are beneficial, access is limited. Internet-delivered MBIs (iMBIs) offer an accessible alternative; yet, qualitative understanding of patient experiences with tailored iMBIs for this specific population is lacking.</p><p><strong>Objective: </strong>This study aimed to explore the facilitators and barriers of patients with HCC post TACE and participated in tailored iMBIs.</p><p><strong>Methods: </strong>From November 2020 to December 2022, 11 patients with HCC post TACE who had taken part in tailored iMBIs were purposively recruited from a tertiary hospital in Jilin Province. Data were collected through semistructured interviews lasting 30-60 minutes. The interviews were analyzed using conventional content analysis.</p><p><strong>Results: </strong>Five main categories emerged from the analysis: (1) mindfulness mindset, including acceptance, calmness, and mood improvement; (2) improvement of physical discomfort, such as better sleep, pain relief, reduced gastrointestinal symptoms, and increased activity levels; (3) resistance to mindfulness practice, including perceived lack of effectiveness, unsuitable conditions, equipment limitations, and difficulty concentrating; (4) support and encouragement, involving social support, supervision, and professional guidance; and (5) accessibility and convenience characterized by restoration of life balance and user-friendly features of the practice. Each category encompassed several subcategories reflecting the diverse experiences of participants.</p><p><strong>Conclusions: </strong>While iMBIs were generally perceived as convenient and accessible, challenges such as equipment limitations were noted. Future implementation should focus on enhancing supportive factors to improve adherence, minimizing barriers, and refining the design and delivery of iMBI programs.</p><p><strong>Trial registration: </strong>Chinese Clinical Trial Registry ChiCTR1900027976; https://www.chictr.org.cn/showproj.html?proj=46657.</p>","PeriodicalId":16337,"journal":{"name":"Journal of Medical Internet Research","volume":"28 ","pages":"e78337"},"PeriodicalIF":6.0,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12902756/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146086107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stephen Potter, Mark Hawley, Angela Higgins, Farshid Amirabdollahian, Mauro Dragone, Alessandro Di Nuovo, Praminda Caleb-Solly
Background: Assistive robotics for helping older people live well and stay independent has, to date, failed to fulfill its promise: there are few assistive robots in everyday use. In part, this failing can be attributed to inadequate or missing co-design activities that would ensure that these technologies and any services that incorporate them are developed with prospective end users, addressing their actual needs and wants, and not merely for them, and based on lazy assumptions about heterogeneous user groups.
Objective: This exercise aimed to address some of these limitations by taking a "phenomenological snapshot" of what it means to be an older person in the current sociotechnological context, and making this snapshot, along with the co-design materials developed, available to the wider assistive robotics community to provide solid foundational evidence for steering the development of assistive robotics in more productive directions.
Methods: Two rounds of co-design workshops have been conducted with older people and their caregivers, based on an innovative methodology that used personas and speculative designs to explore sensitive everyday difficulties faced by participants and highlight some of their general wishes for and concerns about assistive robotics. The data collected during the workshops were analyzed, and key themes were extracted.
Results: Analysis of the workshop data gives access to the lived experience of older people and their caregivers, and their opinions about domestic robotics and assistive technologies more generally. The findings are organized thematically as everyday difficulties, the daily problems faced by older people; ideas for aging better, older people's own suggestions for how their lives could be improved; and living with technology, their preferences and requirements for assistive robots, along with their concerns about what the introduction of robots might mean, both for themselves and for society more widely.
Conclusions: We believe that our findings provide solid foundational evidence for the development of assistive robotics for older people. We are in the process of disseminating these results through various channels to the wider assistive robotics community; ultimately, the success of our activities will be demonstrated only through the development of acceptable, useful, and viable assistive robotics for older people.
{"title":"Assistive Robotics for Healthy Aging: A Foundational Phenomenological Co-Design Exercise.","authors":"Stephen Potter, Mark Hawley, Angela Higgins, Farshid Amirabdollahian, Mauro Dragone, Alessandro Di Nuovo, Praminda Caleb-Solly","doi":"10.2196/77179","DOIUrl":"10.2196/77179","url":null,"abstract":"<p><strong>Background: </strong>Assistive robotics for helping older people live well and stay independent has, to date, failed to fulfill its promise: there are few assistive robots in everyday use. In part, this failing can be attributed to inadequate or missing co-design activities that would ensure that these technologies and any services that incorporate them are developed with prospective end users, addressing their actual needs and wants, and not merely for them, and based on lazy assumptions about heterogeneous user groups.</p><p><strong>Objective: </strong>This exercise aimed to address some of these limitations by taking a \"phenomenological snapshot\" of what it means to be an older person in the current sociotechnological context, and making this snapshot, along with the co-design materials developed, available to the wider assistive robotics community to provide solid foundational evidence for steering the development of assistive robotics in more productive directions.</p><p><strong>Methods: </strong>Two rounds of co-design workshops have been conducted with older people and their caregivers, based on an innovative methodology that used personas and speculative designs to explore sensitive everyday difficulties faced by participants and highlight some of their general wishes for and concerns about assistive robotics. The data collected during the workshops were analyzed, and key themes were extracted.</p><p><strong>Results: </strong>Analysis of the workshop data gives access to the lived experience of older people and their caregivers, and their opinions about domestic robotics and assistive technologies more generally. The findings are organized thematically as everyday difficulties, the daily problems faced by older people; ideas for aging better, older people's own suggestions for how their lives could be improved; and living with technology, their preferences and requirements for assistive robots, along with their concerns about what the introduction of robots might mean, both for themselves and for society more widely.</p><p><strong>Conclusions: </strong>We believe that our findings provide solid foundational evidence for the development of assistive robotics for older people. We are in the process of disseminating these results through various channels to the wider assistive robotics community; ultimately, the success of our activities will be demonstrated only through the development of acceptable, useful, and viable assistive robotics for older people.</p>","PeriodicalId":16337,"journal":{"name":"Journal of Medical Internet Research","volume":"28 ","pages":"e77179"},"PeriodicalIF":6.0,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12895153/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lingyi Fu, Ryan Burns, Yuhuan Xie, Jincheng Shen, Shandian Zhe, Paul Estabrooks, Yang Bai
<p><strong>Background: </strong>Artificial intelligence (AI) chatbots are technologies that facilitate human-computer interaction through communication in a natural language format. By increasing cost-effectiveness, interaction, autonomy, personalization, and support, mobile health interventions can benefit health behavior change and make it more natural and intuitive.</p><p><strong>Objective: </strong>This study aimed to provide an up-to-date and practical overview of how text-based AI chatbots are designed, developed, and evaluated across 8 health behaviors, including their roles, theoretical foundations, health behavior change techniques, technology development workflow, and performance validation framework.</p><p><strong>Methods: </strong>In accordance with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) framework, relevant studies published before March 2024 were identified from 9 bibliographic databases (ie, PubMed, CINAHL, MEDLINE, Embase, Web of Science, Scopus, APA PsycINFO, IEEE Xplore, and ACM Digital Library). Two stages (ie, title and abstract screening followed by full-text screening) were conducted to screen the eligibility of the papers via Covidence software. Finally, we extracted the data via Microsoft Excel software and used a narrative approach, content analysis, and evidence map to synthesize the reported results.</p><p><strong>Results: </strong>Our systematic search initially identified 10,508 publications, 43 of which met our inclusion criteria. AI chatbots primarily served 2 main roles: routine coach (27/43, 62.79%) and on-demand assistant (12/43, 27.91%), while 4 studies (4/43, 9.30%) integrated both roles. Frameworks like cognitive behavioral therapy (13/24, 54.17%) and behavior change techniques, such as goal setting, feedback and monitoring, and social support, guided the development of theory-driven AI chatbots. Noncode platforms (eg, Google Dialogflow and IBM Watson) integrated with social messaging platforms (eg, Facebook Messenger) were commonly used to develop AI chatbots (23/43, 53.49%). AI chatbots have been evaluated across 4 domains: technical performance (17/43, 39.53%), usability (17/43, 39.53%), engagement (37/43, 86.05%), and health behavior change (33/43, 76.74%). Evidence for health behavior changes remains exploratory but promising. Among 33 studies with 120 comparisons, 81.67% (98/120) showed positive outcomes, though only 35.83% (43/120) had moderate or larger effects (Hedges g or odds ratio or Cohen d>0.5). Most involved nonclinical (36/43, 83.72%) and adults (23/43, 53.49%), and a few were randomized controlled trials (14/43, 32.56%). Benefits were mainly seen in physical activity, smoking cessation, stress management, and diet, with limited evidence for other behaviors. Findings were inconsistent regarding the influence of long-term effects, intervention duration, modality, and engagement on health behavior change outcomes.</p><p><st
背景:人工智能(AI)聊天机器人是一种通过自然语言格式的通信促进人机交互的技术。通过提高成本效益、互动、自主、个性化和支持,移动卫生干预措施可有利于卫生行为改变,使其更加自然和直观。目的:本研究旨在为基于文本的人工智能聊天机器人的设计、开发和评估提供最新和实用的概述,包括它们的角色、理论基础、健康行为改变技术、技术开发流程和性能验证框架。方法:按照PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and meta - analysis extension for Scoping Reviews)框架,从9个书目数据库(PubMed、CINAHL、MEDLINE、Embase、Web of Science、Scopus、APA PsycINFO、IEEE Xplore和ACM Digital Library)中检索2024年3月前发表的相关研究。通过covid - ence软件筛选论文的合格性分为两个阶段(即标题和摘要筛选,然后是全文筛选)。最后,我们通过Microsoft Excel软件提取数据,并采用叙述方法、内容分析和证据图对报告结果进行综合。结果:我们的系统检索最初确定了10,508篇出版物,其中43篇符合我们的纳入标准。AI聊天机器人主要扮演两个主要角色:日常教练(27/43,62.79%)和点选助手(12/43,27.91%),有4项研究(4/43,9.30%)将这两个角色整合在一起。认知行为疗法(13/24,54.17%)和行为改变技术(如目标设定、反馈和监控、社会支持)等框架指导了理论驱动型人工智能聊天机器人的发展。非代码平台(如谷歌Dialogflow和IBM Watson)与社交消息平台(如Facebook Messenger)集成在一起,通常用于开发人工智能聊天机器人(23/43,53.49%)。人工智能聊天机器人在4个领域进行了评估:技术性能(17/43,39.53%)、可用性(17/43,39.53%)、参与度(37/43,86.05%)和健康行为改变(33/43,76.74%)。健康行为改变的证据仍然是探索性的,但很有希望。33项研究共120组比较中,81.67%(98/120)的结果为阳性,但只有35.83%(43/120)的结果为中等或较大的效果(Hedges g or比值比或Cohen d >.5)。大多数涉及非临床(36/43,83.72%)和成人(23/43,53.49%),少数为随机对照试验(14/43,32.56%)。益处主要体现在体育锻炼、戒烟、压力管理和饮食方面,其他行为方面的证据有限。关于长期效果、干预持续时间、方式和参与对健康行为改变结果的影响,研究结果不一致。结论:探索性综合为开发和评估人工智能聊天机器人在健康行为改变中的作用提供了路线图,强调需要进一步研究成本、实施结果以及睡眠、体重管理、久坐行为和酒精使用等未被充分探索的行为。
{"title":"The Development and Use of AI Chatbots for Health Behavior Change: Scoping Review.","authors":"Lingyi Fu, Ryan Burns, Yuhuan Xie, Jincheng Shen, Shandian Zhe, Paul Estabrooks, Yang Bai","doi":"10.2196/79677","DOIUrl":"10.2196/79677","url":null,"abstract":"<p><strong>Background: </strong>Artificial intelligence (AI) chatbots are technologies that facilitate human-computer interaction through communication in a natural language format. By increasing cost-effectiveness, interaction, autonomy, personalization, and support, mobile health interventions can benefit health behavior change and make it more natural and intuitive.</p><p><strong>Objective: </strong>This study aimed to provide an up-to-date and practical overview of how text-based AI chatbots are designed, developed, and evaluated across 8 health behaviors, including their roles, theoretical foundations, health behavior change techniques, technology development workflow, and performance validation framework.</p><p><strong>Methods: </strong>In accordance with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) framework, relevant studies published before March 2024 were identified from 9 bibliographic databases (ie, PubMed, CINAHL, MEDLINE, Embase, Web of Science, Scopus, APA PsycINFO, IEEE Xplore, and ACM Digital Library). Two stages (ie, title and abstract screening followed by full-text screening) were conducted to screen the eligibility of the papers via Covidence software. Finally, we extracted the data via Microsoft Excel software and used a narrative approach, content analysis, and evidence map to synthesize the reported results.</p><p><strong>Results: </strong>Our systematic search initially identified 10,508 publications, 43 of which met our inclusion criteria. AI chatbots primarily served 2 main roles: routine coach (27/43, 62.79%) and on-demand assistant (12/43, 27.91%), while 4 studies (4/43, 9.30%) integrated both roles. Frameworks like cognitive behavioral therapy (13/24, 54.17%) and behavior change techniques, such as goal setting, feedback and monitoring, and social support, guided the development of theory-driven AI chatbots. Noncode platforms (eg, Google Dialogflow and IBM Watson) integrated with social messaging platforms (eg, Facebook Messenger) were commonly used to develop AI chatbots (23/43, 53.49%). AI chatbots have been evaluated across 4 domains: technical performance (17/43, 39.53%), usability (17/43, 39.53%), engagement (37/43, 86.05%), and health behavior change (33/43, 76.74%). Evidence for health behavior changes remains exploratory but promising. Among 33 studies with 120 comparisons, 81.67% (98/120) showed positive outcomes, though only 35.83% (43/120) had moderate or larger effects (Hedges g or odds ratio or Cohen d>0.5). Most involved nonclinical (36/43, 83.72%) and adults (23/43, 53.49%), and a few were randomized controlled trials (14/43, 32.56%). Benefits were mainly seen in physical activity, smoking cessation, stress management, and diet, with limited evidence for other behaviors. Findings were inconsistent regarding the influence of long-term effects, intervention duration, modality, and engagement on health behavior change outcomes.</p><p><st","PeriodicalId":16337,"journal":{"name":"Journal of Medical Internet Research","volume":"28 ","pages":"e79677"},"PeriodicalIF":6.0,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12895150/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146086122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sundresan Naicker, Paul Schmidt, Bruce Shar, Amina Tariq, Ashleigh Earnshaw, Steven McPhail
<p><strong>Background: </strong>Medical imaging remains at the forefront of advancements in adopting digital health technologies in clinical practice. Regulator-approved artificial intelligence (AI) clinical decision support systems are commercially available and being embedded into routine practices for radiologists internationally. These decision support solutions show promising clinical validity compared to standard practice conditions; however, their implementation over time and implications on radiologists' practice are poorly understood.</p><p><strong>Objective: </strong>This paper aims to examine the real-world implementation of an AI clinical decision support tool in radiology through a qualitative evaluation across pre-, peri-, and postimplementation phases. Specifically, it seeks to identify the key contextual, organizational, and human factors shaping adoption and sustainability, to map these influences using the nonadoption, abandonment, scale-up, spread, and sustainability (NASSS) framework, and to generate insights that inform evidence-based strategies and policy for integrating AI safely and effectively into public hospital imaging services.</p><p><strong>Methods: </strong>This prospective study was conducted in a large public tertiary referral hospital in Brisbane, Queensland, Australia. One-to-one participant interviews were undertaken across the 3 implementation phases. Participants comprised radiology consultants, registrars, and radiographers involved in chest computed tomography studies during the study period. Interviews were guided by the NASSS framework to identify contextual factors influencing implementation.</p><p><strong>Results: </strong>A total of 43 semistructured interviews were conducted across baseline (n=16), peri-implementation (n=9), and postimplementation (n=18) phases, comprising 7 (16%) radiographers, 20 (47%) registrar radiologists, and 16 (37%) consultant radiologists. Across NASSS domains, 56 barriers and 18 enablers were identified at baseline, 55 and 14 during peri-implementation, and 82 and 33 postimplementation. Organizational barriers dominated early phases, while technological issues such as system accuracy, interoperability, and information overload became most prominent during and after rollout. Enablers increased over time, particularly within the technology and value proposition domains, as some clinicians adapted the AI as a secondary safety check. Trust and adoption remained constrained by performance inconsistency, weak communication, and medicolegal uncertainty.</p><p><strong>Conclusions: </strong>The implementation of AI decision support in radiology is as much an organizational and cultural process as a technological one. Clinicians remain willing to engage, but sustainable adoption depends on consolidating early positive experiences and addressing negative ones, embedding communication and training, and maintaining iterative feedback between users, vendors, and system leaders. Applying t
{"title":"Implementing an Artificial Intelligence Decision Support System in Radiology: Prospective Qualitative Evaluation Study Using the Nonadoption Abandonment Scale-Up, Spread, and Sustainability (NASSS) Framework.","authors":"Sundresan Naicker, Paul Schmidt, Bruce Shar, Amina Tariq, Ashleigh Earnshaw, Steven McPhail","doi":"10.2196/80342","DOIUrl":"10.2196/80342","url":null,"abstract":"<p><strong>Background: </strong>Medical imaging remains at the forefront of advancements in adopting digital health technologies in clinical practice. Regulator-approved artificial intelligence (AI) clinical decision support systems are commercially available and being embedded into routine practices for radiologists internationally. These decision support solutions show promising clinical validity compared to standard practice conditions; however, their implementation over time and implications on radiologists' practice are poorly understood.</p><p><strong>Objective: </strong>This paper aims to examine the real-world implementation of an AI clinical decision support tool in radiology through a qualitative evaluation across pre-, peri-, and postimplementation phases. Specifically, it seeks to identify the key contextual, organizational, and human factors shaping adoption and sustainability, to map these influences using the nonadoption, abandonment, scale-up, spread, and sustainability (NASSS) framework, and to generate insights that inform evidence-based strategies and policy for integrating AI safely and effectively into public hospital imaging services.</p><p><strong>Methods: </strong>This prospective study was conducted in a large public tertiary referral hospital in Brisbane, Queensland, Australia. One-to-one participant interviews were undertaken across the 3 implementation phases. Participants comprised radiology consultants, registrars, and radiographers involved in chest computed tomography studies during the study period. Interviews were guided by the NASSS framework to identify contextual factors influencing implementation.</p><p><strong>Results: </strong>A total of 43 semistructured interviews were conducted across baseline (n=16), peri-implementation (n=9), and postimplementation (n=18) phases, comprising 7 (16%) radiographers, 20 (47%) registrar radiologists, and 16 (37%) consultant radiologists. Across NASSS domains, 56 barriers and 18 enablers were identified at baseline, 55 and 14 during peri-implementation, and 82 and 33 postimplementation. Organizational barriers dominated early phases, while technological issues such as system accuracy, interoperability, and information overload became most prominent during and after rollout. Enablers increased over time, particularly within the technology and value proposition domains, as some clinicians adapted the AI as a secondary safety check. Trust and adoption remained constrained by performance inconsistency, weak communication, and medicolegal uncertainty.</p><p><strong>Conclusions: </strong>The implementation of AI decision support in radiology is as much an organizational and cultural process as a technological one. Clinicians remain willing to engage, but sustainable adoption depends on consolidating early positive experiences and addressing negative ones, embedding communication and training, and maintaining iterative feedback between users, vendors, and system leaders. Applying t","PeriodicalId":16337,"journal":{"name":"Journal of Medical Internet Research","volume":"28 ","pages":"e80342"},"PeriodicalIF":6.0,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12895160/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Background: </strong>Over 50% of people with chronic stroke experience persistent upper limb dysfunction. Brain-computer interface (BCI) therapy, creating a sensorimotor loop via neural feedback, is a promising alternative; yet, its optimal application remains unclear.</p><p><strong>Objective: </strong>This meta-analysis evaluates BCI's efficacy on motor function, tone, and activities of daily living (ADL) in chronic stroke and identifies optimal feedback modalities and intervention parameters.</p><p><strong>Methods: </strong>We systematically searched Cochrane Library, Embase, PubMed, Scopus, Web of Science, and Wanfang Data from inception to October 2025 for randomized controlled trials (RCTs) comparing BCI-based training to control interventions in adults with chronic stroke. Primary outcomes were upper limb motor function (Fugl-Meyer Assessment for upper extremity [FMA-UE], Action Research Arm Test [ARAT]), muscle tone (Modified Ashworth Scale [MAS]), and ADL (Modified Barthel Index [MBI], Motor Activity Log [MAL]). Screening, data extraction, and risk-of-bias assessment were performed independently. Meta-analysis used a random-effects model with Hartung-Knapp-Sidik-Jonkman adjustment. Pooled mean differences (MDs) with 95% CIs and 95% prediction intervals (PIs) were calculated. Subgroup analyses examined feedback modalities, intervention intensity, and follow-up effects. Sensitivity analysis was also conducted.</p><p><strong>Results: </strong>From 3529 records, 21 RCTs (650 participants) were included. BCI training significantly improved motor function (FMA-UE: MD 2.50, 95% CI 0.60-4.40; P=.01; 95% PI -2.52 to 7.22) and ADL performance (MBI: MD 8.38, 95% CI 2.23-14.53; P=.02; 95% PI -3.92 to 20.53; MAL: MD 2.09, 95% CI 0.42-3.76; P=.03; 95% PI -0.69 to 4.54). No significant effects were observed for fine motor skills (ARAT: MD 0.18, 95% CI -0.27 to 0.62; P=.30; 95% PI -3.64 to 3.99) or muscle tone (MAS: MD -0.48, 95% CI -1 to 0.03; P=.06; 95% PI -1.27 to 0.35). Subgroup analyses revealed that BCI-functional electrical stimulation (FES) yielded the greatest improvement in motor recovery (FMA-UE: MD 5, 95% CI 1.86-8.13; P=.01). The optimal intervention protocol was identified as 30-minute sessions, administered 4-5 times per week over 2 weeks (total of 10-12 sessions). However, benefits were not sustained at follow-up.</p><p><strong>Conclusions: </strong>Low- to moderate-certainty evidence suggests that BCI training, particularly the BCI-FES paradigm, can improve upper limb motor function and ADL in people with chronic stroke on average. However, wide prediction intervals indicate the effect may vary substantially across settings, ranging from negligible to beneficial. Subgroup analyses suggested a potential optimal protocol of 30-minute sessions, 4-5 times per week for 2 weeks, but these findings are limited by the small number of studies in each subgroup and the high risk of bias in several included trials. Therefore, this propose
背景:超过50%的慢性中风患者经历持续的上肢功能障碍。脑机接口(BCI)疗法,通过神经反馈创造一个感觉运动回路,是一个很有前途的选择;然而,它的最佳应用仍不清楚。目的:本荟萃分析评估脑机接口对慢性卒中患者运动功能、音调和日常生活活动(ADL)的影响,并确定最佳反馈模式和干预参数。方法:我们系统地检索了Cochrane Library、Embase、PubMed、Scopus、Web of Science和Wanfang Data,检索了从成立到2025年10月的随机对照试验(RCTs),比较了基于bci的训练与控制干预对成年慢性卒中患者的影响。主要结果为上肢运动功能(Fugl-Meyer上肢评估[FMA-UE]、动作研究臂测试[ARAT])、肌肉张力(改良Ashworth量表[MAS])和ADL(改良Barthel指数[MBI]、运动活动日志[MAL])。筛选、数据提取和偏倚风险评估是独立进行的。meta分析采用Hartung-Knapp-Sidik-Jonkman调整的随机效应模型。计算95% ci和95%预测区间的合并平均差异(MDs)。亚组分析检查了反馈方式、干预强度和随访效果。并进行敏感性分析。结果:从3529条记录中,纳入21项随机对照试验(650名受试者)。BCI训练显著改善运动功能(FMA-UE: MD 2.50, 95% CI 0.60-4.40; P= 0.01; 95% PI -2.52至7.22)和ADL表现(MBI: MD 8.38, 95% CI 2.23-14.53; P= 0.02; 95% PI -3.92至20.53;MAL: MD 2.09, 95% CI 0.42-3.76; P= 0.03; 95% PI -0.69至4.54)。在精细运动技能(ARAT: MD 0.18, 95% CI -0.27至0.62;P= 0.30; 95% PI -3.64至3.99)或肌肉张力(MAS: MD -0.48, 95% CI -1至0.03;P= 0.06; 95% PI -1.27至0.35)方面未观察到显著影响。亚组分析显示,脑机接口功能电刺激(FES)对运动恢复的改善最大(FMA-UE: MD 5, 95% CI 1.86-8.13; P= 0.01)。最佳干预方案确定为每次30分钟,每周4-5次,持续2周(共10-12次)。然而,这些益处在随访中并未持续。结论:低到中等确定性的证据表明,BCI训练,特别是BCI- fes模式,可以改善慢性卒中患者的上肢运动功能和ADL。然而,较宽的预测间隔表明,在不同的设置中,效果可能有很大差异,从可以忽略到有益。亚组分析提示可能的最佳方案是每次30分钟,每周4-5次,持续2周,但这些发现受到每个亚组的研究数量较少和几个纳入试验的高偏倚风险的限制。因此,该方案应被视为初步的,需要在未来高质量的随机对照试验中进行验证。未来的研究还应侧重于确定最有可能受益的患者亚组,并制定维持长期收益的策略。试验注册:PROSPERO CRD420251063808;https://www.crd.york.ac.uk/PROSPERO/view/CRD420251063808。
{"title":"Efficacy of Brain-Computer Interface Therapy for Upper Limb Rehabilitation in Chronic Stroke: Systematic Review and Meta-Analysis of Randomized Controlled Trials.","authors":"HongJie Chen, GuoJun Yun","doi":"10.2196/79132","DOIUrl":"10.2196/79132","url":null,"abstract":"<p><strong>Background: </strong>Over 50% of people with chronic stroke experience persistent upper limb dysfunction. Brain-computer interface (BCI) therapy, creating a sensorimotor loop via neural feedback, is a promising alternative; yet, its optimal application remains unclear.</p><p><strong>Objective: </strong>This meta-analysis evaluates BCI's efficacy on motor function, tone, and activities of daily living (ADL) in chronic stroke and identifies optimal feedback modalities and intervention parameters.</p><p><strong>Methods: </strong>We systematically searched Cochrane Library, Embase, PubMed, Scopus, Web of Science, and Wanfang Data from inception to October 2025 for randomized controlled trials (RCTs) comparing BCI-based training to control interventions in adults with chronic stroke. Primary outcomes were upper limb motor function (Fugl-Meyer Assessment for upper extremity [FMA-UE], Action Research Arm Test [ARAT]), muscle tone (Modified Ashworth Scale [MAS]), and ADL (Modified Barthel Index [MBI], Motor Activity Log [MAL]). Screening, data extraction, and risk-of-bias assessment were performed independently. Meta-analysis used a random-effects model with Hartung-Knapp-Sidik-Jonkman adjustment. Pooled mean differences (MDs) with 95% CIs and 95% prediction intervals (PIs) were calculated. Subgroup analyses examined feedback modalities, intervention intensity, and follow-up effects. Sensitivity analysis was also conducted.</p><p><strong>Results: </strong>From 3529 records, 21 RCTs (650 participants) were included. BCI training significantly improved motor function (FMA-UE: MD 2.50, 95% CI 0.60-4.40; P=.01; 95% PI -2.52 to 7.22) and ADL performance (MBI: MD 8.38, 95% CI 2.23-14.53; P=.02; 95% PI -3.92 to 20.53; MAL: MD 2.09, 95% CI 0.42-3.76; P=.03; 95% PI -0.69 to 4.54). No significant effects were observed for fine motor skills (ARAT: MD 0.18, 95% CI -0.27 to 0.62; P=.30; 95% PI -3.64 to 3.99) or muscle tone (MAS: MD -0.48, 95% CI -1 to 0.03; P=.06; 95% PI -1.27 to 0.35). Subgroup analyses revealed that BCI-functional electrical stimulation (FES) yielded the greatest improvement in motor recovery (FMA-UE: MD 5, 95% CI 1.86-8.13; P=.01). The optimal intervention protocol was identified as 30-minute sessions, administered 4-5 times per week over 2 weeks (total of 10-12 sessions). However, benefits were not sustained at follow-up.</p><p><strong>Conclusions: </strong>Low- to moderate-certainty evidence suggests that BCI training, particularly the BCI-FES paradigm, can improve upper limb motor function and ADL in people with chronic stroke on average. However, wide prediction intervals indicate the effect may vary substantially across settings, ranging from negligible to beneficial. Subgroup analyses suggested a potential optimal protocol of 30-minute sessions, 4-5 times per week for 2 weeks, but these findings are limited by the small number of studies in each subgroup and the high risk of bias in several included trials. Therefore, this propose","PeriodicalId":16337,"journal":{"name":"Journal of Medical Internet Research","volume":"28 ","pages":"e79132"},"PeriodicalIF":6.0,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12895162/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146097114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Background: </strong>Cystoscopy remains the gold standard for diagnosing bladder lesions; however, its diagnostic accuracy is operator dependent and prone to missing subtle abnormalities such as carcinoma in situ or misinterpreting mimic lesions (tumor, inflammation, or normal variants). Artificial intelligence-based image-analysis systems are emerging, yet conventional models remain limited to single tasks and cannot produce explanatory reports or articulate diagnostic reasoning. Multimodal large language models (MM-LLMs) integrate visual recognition, contextual reasoning, and language generation, offering interpretive capabilities beyond conventional artificial intelligence.</p><p><strong>Objective: </strong>This study aims to rigorously evaluate state-of-the-art MM-LLMs for cystoscopic image interpretation and lesion classification using clinician-defined stress-test datasets enriched with rare, diverse, and challenging lesions, focusing on diagnostic accuracy, reasoning quality, and clinical relevance.</p><p><strong>Methods: </strong>Four MM-LLMs (OpenAI-o3 and ChatGPT-4o [OpenAI]; Gemini 2.5 Pro and MedGemma-27B [Google]) were evaluated under blinded, randomized procedures across two tasks: (1) free-text image interpretation for anatomic site, findings, lesion reasoning, and final diagnosis (n=401) and (2) seven-class tumor-like lesion classification (n=113) within a multiple-choice framework (cystitis, polyps, papilloma, papillary urothelial carcinoma, carcinoma in situ, non-urothelial carcinoma, and none of the above). Three raters independently scored outputs using a 5-point Likert scale, and classification metrics (accuracy, sensitivity, specificity, Youden J index (Youden J), and Matthews correlation coefficient [MCC]) were calculated for lesion detection, biopsy indication, and malignancy endpoints. For optimization, model performance was compared between zero-shot and text-based in-context learning prompts that were prefixed with brief descriptions of tumor features.</p><p><strong>Results: </strong>The 401-image test set spanned 40 subcategories, with 322 (80.3%) containing abnormal findings in the image interpretation task. OpenAI-o3 demonstrated strong reasoning, with high satisfaction for anatomy (339/401, 84.5%) and findings (305/401, 76%), but lower satisfaction for lesion reasoning (211/401, 52.5%) and final diagnosis (193/401, 48.2%), indicating increasing difficulty with higher-order synthesis. Mean Likert score differences (OpenAI-o3 minus Gemini 2.5 Pro) were +0.27 for findings (adjusted P value: q=0.002), +0.24 for lesion reasoning (q=0.047), and +0.19 for final diagnosis. For clinically relevant endpoints in the full set, OpenAI-o3 achieved the most balanced performance, with lesion detection accuracy of 88.3%, sensitivity of 92%, specificity of 73.1%, Youden J of 0.650, and MCC of 0.635. In 7-class tumor-like lesion classification, OpenAI-o3 achieved accuracies of 73.5% for biopsy indication and 62.8% for malig
{"title":"Multimodal Large Language Models for Cystoscopic Image Interpretation and Bladder Lesion Classification: Comparative Study.","authors":"Yung-Chi Shih, Cheng-Yang Wu, Shi-Wei Huang, Chung-You Tsai","doi":"10.2196/87193","DOIUrl":"10.2196/87193","url":null,"abstract":"<p><strong>Background: </strong>Cystoscopy remains the gold standard for diagnosing bladder lesions; however, its diagnostic accuracy is operator dependent and prone to missing subtle abnormalities such as carcinoma in situ or misinterpreting mimic lesions (tumor, inflammation, or normal variants). Artificial intelligence-based image-analysis systems are emerging, yet conventional models remain limited to single tasks and cannot produce explanatory reports or articulate diagnostic reasoning. Multimodal large language models (MM-LLMs) integrate visual recognition, contextual reasoning, and language generation, offering interpretive capabilities beyond conventional artificial intelligence.</p><p><strong>Objective: </strong>This study aims to rigorously evaluate state-of-the-art MM-LLMs for cystoscopic image interpretation and lesion classification using clinician-defined stress-test datasets enriched with rare, diverse, and challenging lesions, focusing on diagnostic accuracy, reasoning quality, and clinical relevance.</p><p><strong>Methods: </strong>Four MM-LLMs (OpenAI-o3 and ChatGPT-4o [OpenAI]; Gemini 2.5 Pro and MedGemma-27B [Google]) were evaluated under blinded, randomized procedures across two tasks: (1) free-text image interpretation for anatomic site, findings, lesion reasoning, and final diagnosis (n=401) and (2) seven-class tumor-like lesion classification (n=113) within a multiple-choice framework (cystitis, polyps, papilloma, papillary urothelial carcinoma, carcinoma in situ, non-urothelial carcinoma, and none of the above). Three raters independently scored outputs using a 5-point Likert scale, and classification metrics (accuracy, sensitivity, specificity, Youden J index (Youden J), and Matthews correlation coefficient [MCC]) were calculated for lesion detection, biopsy indication, and malignancy endpoints. For optimization, model performance was compared between zero-shot and text-based in-context learning prompts that were prefixed with brief descriptions of tumor features.</p><p><strong>Results: </strong>The 401-image test set spanned 40 subcategories, with 322 (80.3%) containing abnormal findings in the image interpretation task. OpenAI-o3 demonstrated strong reasoning, with high satisfaction for anatomy (339/401, 84.5%) and findings (305/401, 76%), but lower satisfaction for lesion reasoning (211/401, 52.5%) and final diagnosis (193/401, 48.2%), indicating increasing difficulty with higher-order synthesis. Mean Likert score differences (OpenAI-o3 minus Gemini 2.5 Pro) were +0.27 for findings (adjusted P value: q=0.002), +0.24 for lesion reasoning (q=0.047), and +0.19 for final diagnosis. For clinically relevant endpoints in the full set, OpenAI-o3 achieved the most balanced performance, with lesion detection accuracy of 88.3%, sensitivity of 92%, specificity of 73.1%, Youden J of 0.650, and MCC of 0.635. In 7-class tumor-like lesion classification, OpenAI-o3 achieved accuracies of 73.5% for biopsy indication and 62.8% for malig","PeriodicalId":16337,"journal":{"name":"Journal of Medical Internet Research","volume":"28 ","pages":"e87193"},"PeriodicalIF":6.0,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12895159/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Background: </strong>As artificial intelligence (AI) becomes increasingly embedded in clinical decision-making and preventive care, it is urgent to address ethical concerns such as bias, privacy, and transparency to protect clinician and patient populations. Although prior research has examined the perspectives of medical AI stakeholders, including clinicians, patients, and health system leaders, far less is known about how medical AI developers and researchers understand and engage with ethical challenges as they develop AI tools. This gap is consequential because developers' ethical awareness, decision-making, and institutional environments influence how AI tools are conceptualized and deployed in practice. Thus, it is essential to understand how developers perceive these issues and what supports they identify as necessary for ethical AI development.</p><p><strong>Objective: </strong>The objectives of the study were twofold: (1) to examine medical AI developers' and researchers' knowledge, attitudes, and experiences with AI ethics; and (2) to identify recommendations to enhance and strengthen interpersonal and institutional ethics-focused training and support.</p><p><strong>Methods: </strong>We conducted 2 semistructured focus groups (60-90 minutes each) in 2024 with 13 AI developers and researchers affiliated with 5 US-based academic institutions. Participants' work spanned a wide variety of medical AI applications, including Alzheimer disease prediction, clinical imaging, electronic health records analysis, digital health, counseling and behavioral health, and genotype-phenotype modeling. Focus groups were conducted via Microsoft Teams, recorded, and transcribed verbatim. We applied conventional qualitative content analysis to inductively identify emerging concepts, categories, and themes. Coding was performed independently by 3 researchers, with consensus reached through iterative team meetings.</p><p><strong>Results: </strong>The analysis identified four key themes: (1) AI ethics knowledge acquisition: participants reported learning about ethics informally through peer-reviewed literature, reviewer feedback, social media, and mentorship rather than through structured training; (2) ethical encounters: participants described recurring ethical challenges related to data bias, patient privacy, generative AI use, commercialization pressures, and a tendency for research environments to prioritize model accuracy over ethical reflection; (3) reflections on ethical implications: participants expressed concern about downstream effects on patient care and clinician autonomy, and model generalizability, noting that rapid technological innovation outpaces regulatory and evaluative processes; and (4) strategies to mitigate ethical concerns: recommendations included clearer institutional guidelines, ethics checklists, interdisciplinary collaboration, multi-institutional data sharing, enhanced institutional review board support, and the inclusio
{"title":"Ethical Knowledge, Challenges, and Institutional Strategies Among Medical AI Developers and Researchers: Focus Group Study.","authors":"Sophia Fantus, Jinxu Li, Tianci Wang, Lu Tang","doi":"10.2196/79613","DOIUrl":"10.2196/79613","url":null,"abstract":"<p><strong>Background: </strong>As artificial intelligence (AI) becomes increasingly embedded in clinical decision-making and preventive care, it is urgent to address ethical concerns such as bias, privacy, and transparency to protect clinician and patient populations. Although prior research has examined the perspectives of medical AI stakeholders, including clinicians, patients, and health system leaders, far less is known about how medical AI developers and researchers understand and engage with ethical challenges as they develop AI tools. This gap is consequential because developers' ethical awareness, decision-making, and institutional environments influence how AI tools are conceptualized and deployed in practice. Thus, it is essential to understand how developers perceive these issues and what supports they identify as necessary for ethical AI development.</p><p><strong>Objective: </strong>The objectives of the study were twofold: (1) to examine medical AI developers' and researchers' knowledge, attitudes, and experiences with AI ethics; and (2) to identify recommendations to enhance and strengthen interpersonal and institutional ethics-focused training and support.</p><p><strong>Methods: </strong>We conducted 2 semistructured focus groups (60-90 minutes each) in 2024 with 13 AI developers and researchers affiliated with 5 US-based academic institutions. Participants' work spanned a wide variety of medical AI applications, including Alzheimer disease prediction, clinical imaging, electronic health records analysis, digital health, counseling and behavioral health, and genotype-phenotype modeling. Focus groups were conducted via Microsoft Teams, recorded, and transcribed verbatim. We applied conventional qualitative content analysis to inductively identify emerging concepts, categories, and themes. Coding was performed independently by 3 researchers, with consensus reached through iterative team meetings.</p><p><strong>Results: </strong>The analysis identified four key themes: (1) AI ethics knowledge acquisition: participants reported learning about ethics informally through peer-reviewed literature, reviewer feedback, social media, and mentorship rather than through structured training; (2) ethical encounters: participants described recurring ethical challenges related to data bias, patient privacy, generative AI use, commercialization pressures, and a tendency for research environments to prioritize model accuracy over ethical reflection; (3) reflections on ethical implications: participants expressed concern about downstream effects on patient care and clinician autonomy, and model generalizability, noting that rapid technological innovation outpaces regulatory and evaluative processes; and (4) strategies to mitigate ethical concerns: recommendations included clearer institutional guidelines, ethics checklists, interdisciplinary collaboration, multi-institutional data sharing, enhanced institutional review board support, and the inclusio","PeriodicalId":16337,"journal":{"name":"Journal of Medical Internet Research","volume":"28 ","pages":"e79613"},"PeriodicalIF":6.0,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12895146/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yi Zhou, Jessica Rees, Faith Matcham, Ashay Patel, Michela Antonelli, Anthea Tinker, Sebastien Ourselin, Wei Liu
<p><strong>Background: </strong>Loneliness is a critical issue among older adults and constitutes a significant risk factor for a range of physical and mental health conditions. However, current assessment methods primarily rely on self-report questionnaires and clinical evaluations, which are susceptible to recall bias and social desirability bias, highlighting the need for more objective and continuous assessment approaches. Recent studies have reported associations between physiological and behavioral indicators and the experience of loneliness in older adults. While these technologies have demonstrated correlations between physiological and behavioral sensor data and the experience of loneliness, their implementation has been limited. Most systems rely on fixed-location sensors or smartphone apps, with little attention given to the integration of these tools into users' daily routines. To date, no published studies have applied smart textile technology, which integrates sensing capabilities directly into garments or furniture, as a medium for loneliness detection. This study addresses that gap by exploring the usability, experiential acceptability, and ethical considerations of smart textile-based monitoring systems.</p><p><strong>Objective: </strong>This study aims to assess the perceived usability, acceptability, and emotional resonance of a smart loneliness monitoring system integrating sensing garments, furniture, and a mobile app and identify design implications to guide future improvement and promote sustained engagement among older adults.</p><p><strong>Methods: </strong>Building on earlier conceptual research, a functional prototype system was developed and evaluated through 2 immersive in-person workshops with older adults (N=10). A mixed methods approach was applied, combining structured questionnaires, sensory ethnographic observations, focus group discussions, and experience-based co-design. Quantitative data were analyzed descriptively, and qualitative data were analyzed thematically to explore user perceptions related to system usability, emotional response, lifestyle compatibility, and ethical considerations.</p><p><strong>Results: </strong>Quantitative data indicated high user satisfaction in dimensions such as comfort, ease of use, and feedback clarity. However, trust in long-term monitoring and willingness to use the system regularly varied. Thematic analysis revealed 4 main areas influencing acceptance, including wearability, usability, and daily integration; trust, privacy, and data control; perceptions of loneliness and the limits of detection; and adoption, applicability, and ethical futures. Participants emphasized the need for discretion, personalization, and human oversight in system feedback and data-sharing mechanisms.</p><p><strong>Conclusions: </strong>The resulting prototype was positively received, demonstrating the potential of smart systems for passive and personalized loneliness monitoring among older adults.
{"title":"Development and User-Centered Evaluation of Smart Systems for Loneliness Monitoring in Older Adults: Mixed Methods Study.","authors":"Yi Zhou, Jessica Rees, Faith Matcham, Ashay Patel, Michela Antonelli, Anthea Tinker, Sebastien Ourselin, Wei Liu","doi":"10.2196/81027","DOIUrl":"10.2196/81027","url":null,"abstract":"<p><strong>Background: </strong>Loneliness is a critical issue among older adults and constitutes a significant risk factor for a range of physical and mental health conditions. However, current assessment methods primarily rely on self-report questionnaires and clinical evaluations, which are susceptible to recall bias and social desirability bias, highlighting the need for more objective and continuous assessment approaches. Recent studies have reported associations between physiological and behavioral indicators and the experience of loneliness in older adults. While these technologies have demonstrated correlations between physiological and behavioral sensor data and the experience of loneliness, their implementation has been limited. Most systems rely on fixed-location sensors or smartphone apps, with little attention given to the integration of these tools into users' daily routines. To date, no published studies have applied smart textile technology, which integrates sensing capabilities directly into garments or furniture, as a medium for loneliness detection. This study addresses that gap by exploring the usability, experiential acceptability, and ethical considerations of smart textile-based monitoring systems.</p><p><strong>Objective: </strong>This study aims to assess the perceived usability, acceptability, and emotional resonance of a smart loneliness monitoring system integrating sensing garments, furniture, and a mobile app and identify design implications to guide future improvement and promote sustained engagement among older adults.</p><p><strong>Methods: </strong>Building on earlier conceptual research, a functional prototype system was developed and evaluated through 2 immersive in-person workshops with older adults (N=10). A mixed methods approach was applied, combining structured questionnaires, sensory ethnographic observations, focus group discussions, and experience-based co-design. Quantitative data were analyzed descriptively, and qualitative data were analyzed thematically to explore user perceptions related to system usability, emotional response, lifestyle compatibility, and ethical considerations.</p><p><strong>Results: </strong>Quantitative data indicated high user satisfaction in dimensions such as comfort, ease of use, and feedback clarity. However, trust in long-term monitoring and willingness to use the system regularly varied. Thematic analysis revealed 4 main areas influencing acceptance, including wearability, usability, and daily integration; trust, privacy, and data control; perceptions of loneliness and the limits of detection; and adoption, applicability, and ethical futures. Participants emphasized the need for discretion, personalization, and human oversight in system feedback and data-sharing mechanisms.</p><p><strong>Conclusions: </strong>The resulting prototype was positively received, demonstrating the potential of smart systems for passive and personalized loneliness monitoring among older adults.","PeriodicalId":16337,"journal":{"name":"Journal of Medical Internet Research","volume":"28 ","pages":"e81027"},"PeriodicalIF":6.0,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12895156/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Interoperability has been a challenge for half a century. Led by an informatics view of the world, the quest for interoperability has evolved from typing and categorizing data to building increasingly complex models. In parallel with the development of these models, the field of terminologies and ontologies emerged to refine granularity and introduce notions of hierarchy. Clinical data models and terminology systems vary in purpose, and their fixed categories shape and constrain representation, which inevitably leads to information loss.
Objective: Despite these efforts, semantic interoperability remains imperfect. Achieving it is essential for effective data reuse but requires more than rich terminologies and standardized models. This methodological study explores the extent to which the SNOMED CT (Systematized Nomenclature of Medicine - Clinical Terms) compositional grammar can be leveraged and extended to approximate a formal descriptive grammar, allowing clinical reality to be expressed in coherent, meaningful sentences rather than preconstrained categories.
Methods: Building on a decade of semantic representation efforts at the Geneva University Hospitals, we developed a framework to identify recurring semantic gaps in clinical data. We addressed these gaps by systematically modifying the SNOMED CT Machine Read` Concept Model and extending its Augmented Backus-Naur Form syntax to support necessary grammatical structures and external vocabularies.
Results: This approach enabled the semantic representation of over 119,000 distinct data elements covering 13 billion instances. By extending the grammar, we successfully addressed critical limitations such as negation, scalar values, uncertainty, temporality, and the integration of external terminologies like Pango. The extensions proved essential for capturing complex clinical nuances that standard precoordinated concepts could not represent.
Conclusions: Rather than creating a new standard from scratch, extending the grammatical capabilities of SNOMED CT offers a viable pathway toward high-fidelity semantic representation. This work serves as a proof-of-concept that separating the rules of composition from vocabulary allows for a more flexible and robust description of clinical reality, provided that challenges regarding governance and machine readability are addressed.
{"title":"Extended Grammar of Systematized Nomenclature of Medicine - Clinical Terms for Semantic Representation of Clinical Data: Methodological Study.","authors":"Christophe Gaudet-Blavignac, Julien Ehrsam, Monika Baumann, Adel Bensahla, Mirjam Mattei, Yuanyuan Zheng, Christian Lovis","doi":"10.2196/80314","DOIUrl":"10.2196/80314","url":null,"abstract":"<p><strong>Background: </strong>Interoperability has been a challenge for half a century. Led by an informatics view of the world, the quest for interoperability has evolved from typing and categorizing data to building increasingly complex models. In parallel with the development of these models, the field of terminologies and ontologies emerged to refine granularity and introduce notions of hierarchy. Clinical data models and terminology systems vary in purpose, and their fixed categories shape and constrain representation, which inevitably leads to information loss.</p><p><strong>Objective: </strong>Despite these efforts, semantic interoperability remains imperfect. Achieving it is essential for effective data reuse but requires more than rich terminologies and standardized models. This methodological study explores the extent to which the SNOMED CT (Systematized Nomenclature of Medicine - Clinical Terms) compositional grammar can be leveraged and extended to approximate a formal descriptive grammar, allowing clinical reality to be expressed in coherent, meaningful sentences rather than preconstrained categories.</p><p><strong>Methods: </strong>Building on a decade of semantic representation efforts at the Geneva University Hospitals, we developed a framework to identify recurring semantic gaps in clinical data. We addressed these gaps by systematically modifying the SNOMED CT Machine Read` Concept Model and extending its Augmented Backus-Naur Form syntax to support necessary grammatical structures and external vocabularies.</p><p><strong>Results: </strong>This approach enabled the semantic representation of over 119,000 distinct data elements covering 13 billion instances. By extending the grammar, we successfully addressed critical limitations such as negation, scalar values, uncertainty, temporality, and the integration of external terminologies like Pango. The extensions proved essential for capturing complex clinical nuances that standard precoordinated concepts could not represent.</p><p><strong>Conclusions: </strong>Rather than creating a new standard from scratch, extending the grammatical capabilities of SNOMED CT offers a viable pathway toward high-fidelity semantic representation. This work serves as a proof-of-concept that separating the rules of composition from vocabulary allows for a more flexible and robust description of clinical reality, provided that challenges regarding governance and machine readability are addressed.</p>","PeriodicalId":16337,"journal":{"name":"Journal of Medical Internet Research","volume":"28 ","pages":"e80314"},"PeriodicalIF":6.0,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12895155/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jörg Matthes, Anne Reinhardt, Selma Hodzic, Jaroslava Kaňková, Alice Binder, Ljubisa Bojic, Helle Terkildsen Maindal, Corina Paraschiv, Knud Ryom
<p><strong>Background: </strong>The rise of generative artificial intelligence (AI) tools such as ChatGPT is rapidly transforming how people access information online. In the health context, generative AI is seen as a potentially disruptive information source due to its low entry barriers, conversational style, and ability to tailor content to users' needs. However, little is known about whether and how individuals use generative AI for health purposes, and which groups may benefit or be left behind, raising important questions of digital health equity.</p><p><strong>Objective: </strong>This study aimed to assess the current relevance of generative AI as a health information source and to identify key factors predicting individuals' intention to use it. We applied the Unified Theory of Acceptance and Use of Technology 2, focusing on 6 core predictors: performance expectancy, effort expectancy, facilitating conditions, social influence, habit, and hedonic motivation. In addition, we extended the model by including health literacy and health status. A cross-national design enabled comparison across 4 European countries.</p><p><strong>Methods: </strong>A representative online survey was conducted in September 2024 with 1990 participants aged 16 to 74 years from Austria (n=502), Denmark (n=507), France (n=498), and Serbia (n=483). Structural equation modeling with metric measurement invariance was used to test associations across countries.</p><p><strong>Results: </strong>Usage of generative AI for health information was still limited: only 39.5% of respondents reported having used it at least rarely. Generative AI ranked last among all measured health information sources (mean 2.08, SD 1.66); instead, medical experts (mean 4.77, SD 1.70) and online search engines (mean 4.57, SD 1.88) are still the most frequently used health information sources. Despite this, performance expectancy (b range=0.44-0.53; all P<.001), habit (b range=0.28-0.32; all P<.001), and hedonic motivation (b range=0.22-0.45; all P<.001) consistently predicted behavioral intention in all countries. Facilitating conditions also showed small but significant effects (b range=0.12-0.24; all P<.01). In contrast, effort expectancy, social influence, health literacy, and health status were unrelated to intention in all countries, with one marginal exception (France: health status, b=-0.09; P=.007). Model fit was good (comparative fit index=0.95; root mean square error of approximation=0.03), and metric invariance was confirmed.</p><p><strong>Conclusions: </strong>Generative AI use for health information is currently driven by early adopters-those who find it useful, easy to integrate, enjoyable, and have the necessary skills and infrastructure to do so. Cross-national consistency suggests a shared adoption pattern across Europe. To promote equitable adoption, communication efforts should focus on usefulness, convenience, and enjoyment, while ensuring digital access and safeguards for vul
{"title":"Predicting the Intention to Use Generative Artificial Intelligence for Health Information: Comparative Survey Study.","authors":"Jörg Matthes, Anne Reinhardt, Selma Hodzic, Jaroslava Kaňková, Alice Binder, Ljubisa Bojic, Helle Terkildsen Maindal, Corina Paraschiv, Knud Ryom","doi":"10.2196/75648","DOIUrl":"10.2196/75648","url":null,"abstract":"<p><strong>Background: </strong>The rise of generative artificial intelligence (AI) tools such as ChatGPT is rapidly transforming how people access information online. In the health context, generative AI is seen as a potentially disruptive information source due to its low entry barriers, conversational style, and ability to tailor content to users' needs. However, little is known about whether and how individuals use generative AI for health purposes, and which groups may benefit or be left behind, raising important questions of digital health equity.</p><p><strong>Objective: </strong>This study aimed to assess the current relevance of generative AI as a health information source and to identify key factors predicting individuals' intention to use it. We applied the Unified Theory of Acceptance and Use of Technology 2, focusing on 6 core predictors: performance expectancy, effort expectancy, facilitating conditions, social influence, habit, and hedonic motivation. In addition, we extended the model by including health literacy and health status. A cross-national design enabled comparison across 4 European countries.</p><p><strong>Methods: </strong>A representative online survey was conducted in September 2024 with 1990 participants aged 16 to 74 years from Austria (n=502), Denmark (n=507), France (n=498), and Serbia (n=483). Structural equation modeling with metric measurement invariance was used to test associations across countries.</p><p><strong>Results: </strong>Usage of generative AI for health information was still limited: only 39.5% of respondents reported having used it at least rarely. Generative AI ranked last among all measured health information sources (mean 2.08, SD 1.66); instead, medical experts (mean 4.77, SD 1.70) and online search engines (mean 4.57, SD 1.88) are still the most frequently used health information sources. Despite this, performance expectancy (b range=0.44-0.53; all P<.001), habit (b range=0.28-0.32; all P<.001), and hedonic motivation (b range=0.22-0.45; all P<.001) consistently predicted behavioral intention in all countries. Facilitating conditions also showed small but significant effects (b range=0.12-0.24; all P<.01). In contrast, effort expectancy, social influence, health literacy, and health status were unrelated to intention in all countries, with one marginal exception (France: health status, b=-0.09; P=.007). Model fit was good (comparative fit index=0.95; root mean square error of approximation=0.03), and metric invariance was confirmed.</p><p><strong>Conclusions: </strong>Generative AI use for health information is currently driven by early adopters-those who find it useful, easy to integrate, enjoyable, and have the necessary skills and infrastructure to do so. Cross-national consistency suggests a shared adoption pattern across Europe. To promote equitable adoption, communication efforts should focus on usefulness, convenience, and enjoyment, while ensuring digital access and safeguards for vul","PeriodicalId":16337,"journal":{"name":"Journal of Medical Internet Research","volume":"28 ","pages":"e75648"},"PeriodicalIF":6.0,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12851524/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146093398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}